Waltham, MA - January 15, 2008 - Magen BioSciences, Inc., announced today the appointment of David E. Fisher, M.D., Ph.D. as the new Chairman of Dermatology at Massachusetts General Hospital (MGH), effective January 1, 2008. Dr. Fisher is a co-founder of Magen Biosciences, Inc. a privately held dermatology specialty pharmaceutical company. In addition to this position, Dr. Fisher will also be the Director of the Melanoma Program in Medical Oncology and the Director of the Cutaneous Biology Research Center all at MGH.

"We are delighted by David's appointment and look forward to continuing to work closely with him in our research and development programs at Magen," said Brian M. Gallagher, Ph.D., President and CEO of Magen. Dr. Fisher is also Chairman of Magen's Scientific Advisory Board and a member of the company's Board of Directors.

About Magen BioSciences
Magen BioSciences was founded in 2006 by an outstanding group of scientists and investors to build a science-based dermatology company. The company is a research and development stage enterprise that acquires and develops novel and proprietary technologies and is headquartered in Waltham, Massachusetts.